The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Symbicort Turbuhaler contains two active ingredients in one inhaler: ...

AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response ...

AstraZeneca and Astellas Pharma Inc. today announced an agreement for the co-promotion of AstraZeneca's Symbicort Turbuhaler (budesonide/ formoterol, a dry powder inhaler), for the treatment of ...

The results showed a a 51% reduction in the rate of annual asthma exacerbations compared to albuterol. AstraZeneca’s Novel START trial for its Symbicort Turbuhaler ...

AstraZeneca has unveiled data from two Phase III trials showing the benefit of using Symbicort Turbuhaler as an anti-inflammatory reliever ‘as needed’ versus two different treatment regimens in ...

LONDON (Alliance News) - AstraZeneca PLC's Novel Start trial for its Symbicort Turbuhaler demonstrated a reduction in the rate of asthma attacks in patients with mild asthma compared to common ...

(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced the approval of the company's Symbicort Turbuhaler in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to achieve ...

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...

Study Highlights Improved Outcomes for Asthma Patients Including Fewer Exacerbations Following Change in Treatment to DuoResp Spiromax(R) Teva Pharmaceuticals Europe B.V., today announced data from a ...

The US District Court for the Northern District of West Virginia has decided in favour of AstraZeneca in litigation against Mylan Pharmaceuticals Inc. (Mylan) and Kindeva Drug Delivery L.P. (Kindeva), ...